Literature DB >> 9773787

Functional studies of twelve mutant V2 vasopressin receptors related to nephrogenic diabetes insipidus: molecular basis of a mild clinical phenotype.

Y Ala1, D Morin, B Mouillac, N Sabatier, R Vargas, N Cotte, M Déchaux, C Antignac, M F Arthus, M Lonergan, M S Turner, M N Balestre, G Alonso, M Hibert, C Barberis, G N Hendy, D G Bichet, S Jard.   

Abstract

X-linked nephrogenic diabetes insipidus (NDI) is a rare disease with defective renal and extrarenal arginine vasopressin V2 receptor responses due to mutations in the AVPR2 gene in Xq28. To study the cause of loss of function of mutant V2 receptors, we expressed 12 mutations (N55H, L59P, L83Q, V88M, 497CC-->GG, deltaR202, I209F, 700delC, 908insT, A294P, P322H, P322S) in COS-7 cells. Eleven of these, including P322H, were characterized by a complete loss of function, but the mutation P322S demonstrated a mild clinical and in vitro phenotype. This was characterized by a late diagnosis without any growth or developmental delay and a significant increase in urine osmolality after intravenous 1-deamino[D-Arg8]AVP administration. In vitro, the P322S mutant was able to partially activate the Gs/adenylyl cyclase system in contrast to the other V2R mutants including P322H, which were completely inactive in this regard. This showed not only that Pro 322 is important for proper V2R coupling, but also that the degree of impairment is strongly dependent on the identity of the substituting amino acid. Three-dimensional modeling of the P322H and P322S mutant receptors suggested that the complete loss of function of the P322H receptor could be due, in part, to hydrogen bond formation between the His 322 side chain and the carboxyl group of Asp 85, which does not occur in the P322S receptor.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9773787     DOI: 10.1681/ASN.V9101861

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  19 in total

1.  V2 vasopressin receptor (V2R) mutations in partial nephrogenic diabetes insipidus highlight protean agonism of V2R antagonists.

Authors:  Kazuhiro Takahashi; Noriko Makita; Katsunori Manaka; Masataka Hisano; Yuko Akioka; Kenichiro Miura; Noriyuki Takubo; Atsuko Iida; Norishi Ueda; Makiko Hashimoto; Toshiro Fujita; Takashi Igarashi; Takashi Sekine; Taroh Iiri
Journal:  J Biol Chem       Date:  2011-12-05       Impact factor: 5.157

2.  Novel mutations associated with nephrogenic diabetes insipidus. A clinical-genetic study.

Authors:  Alejandro García Castaño; Gustavo Pérez de Nanclares; Leire Madariaga; Mireia Aguirre; Sara Chocron; Alvaro Madrid; Francisco Javier Lafita Tejedor; Mercedes Gil Campos; Jaime Sánchez Del Pozo; Rafael Ruiz Cano; Mar Espino; Jose Maria Gomez Vida; Fernando Santos; Victor Manuel García Nieto; Reyner Loza; Luis Miguel Rodríguez; Emilia Hidalgo Barquero; Nikoleta Printza; Juan Antonio Camacho; Luis Castaño; Gema Ariceta
Journal:  Eur J Pediatr       Date:  2015-04-23       Impact factor: 3.183

Review 3.  Congenital nephrogenic diabetes insipidus: the current state of affairs.

Authors:  Daniel Wesche; Peter M T Deen; Nine V A M Knoers
Journal:  Pediatr Nephrol       Date:  2012-03-17       Impact factor: 3.714

Review 4.  Familial forms of diabetes insipidus: clinical and molecular characteristics.

Authors:  Muriel Babey; Peter Kopp; Gary L Robertson
Journal:  Nat Rev Endocrinol       Date:  2011-07-05       Impact factor: 43.330

5.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

6.  Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants.

Authors:  J P Morello; A Salahpour; A Laperrière; V Bernier; M F Arthus; M Lonergan; U Petäjä-Repo; S Angers; D Morin; D G Bichet; M Bouvier
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

Review 7.  Pathophysiology, diagnosis and management of nephrogenic diabetes insipidus.

Authors:  Detlef Bockenhauer; Daniel G Bichet
Journal:  Nat Rev Nephrol       Date:  2015-06-16       Impact factor: 28.314

8.  Culturing primary rat inner medullary collecting duct cells.

Authors:  Dörte Faust; Andrea Geelhaar; Beate Eisermann; Jenny Eichhorst; Burkhard Wiesner; Walter Rosenthal; Enno Klussmann; Enno Klussman
Journal:  J Vis Exp       Date:  2013-06-21       Impact factor: 1.355

9.  Analysis of the V2 Vasopressin Receptor (V2R) Mutations Causing Partial Nephrogenic Diabetes Insipidus Highlights a Sustainable Signaling by a Non-peptide V2R Agonist.

Authors:  Noriko Makita; Tomohiko Sato; Yuki Yajima-Shoji; Junichiro Sato; Katsunori Manaka; Makiko Eda-Hashimoto; Masanori Ootaki; Naoki Matsumoto; Masaomi Nangaku; Taroh Iiri
Journal:  J Biol Chem       Date:  2016-09-06       Impact factor: 5.157

Review 10.  Urinary concentration: different ways to open and close the tap.

Authors:  Detlef Bockenhauer; Daniel G Bichet
Journal:  Pediatr Nephrol       Date:  2013-06-06       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.